Dr. Agarwal's Health Care (AHCL) proposes merging Dr. Agarwal's Eye Hospital (AEHL) into itself, creating a single listed entity. AEHL shareholders (excluding AHCL) will receive 23 AHCL shares for every 2 AEHL shares. This aims to simplify the group structure, enhance shareholder value, and drive operational efficiencies, with the merger expected by Q2 FY27.
AHCL reported FY25 revenue of ₹1,711 Cr (up 28.4% YoY), EBITDA of ₹502 Cr (up 23.6%), and PAT of ₹110 Cr (up 16.1%). AEHL's FY25 total income was ₹402 Cr (up 24%), with EBITDA at ₹124 Cr (up 28.7%) and PAT at ₹55 Cr (up 17.9%). The combined entity anticipates unified growth.